Meta-analysis from published database demonstrated that GREB1 expression is significantly increased in ER-positive cancer patients compared to ER-negative cancer patients (Figure 2B) [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47]. The gene discussed is GREB1; the disease is cancer.